Search results for "L. Bueno. Mechanisms involved in bacterial pathogen-induced intestinal mucosal barrier disruption: Therapeutic interest of mecha"
J Cell Sci 2017 (Journal of Cell Science)
Mucosal barriers separate self from non-self and are essential for life. These barriers, which are the first line of defense against external pathogens, are formed by epithelial cells and the substances they secrete.
Eur Rev Med Pharmacol Sci . 2017; 21 (4): 873-883
Researchers from the A. Gemelli Foundation, School of Medicine, Rome, Italy have published an extensive review on the role of Gelatin tannate and tyndallized probiotics (Tasectan Duo) in the treatment of diarrhea.
N Engl J Med 2017; 376:2566-78
New article in NEJM supports the role of increased intestinal permeability in the pathophysiology of IBS.
We are pleased to announce the launch in France of UTIPRO® PLUS, our product for uncomplicated Urinary Tract Infections. The product is commercialized over the French territory under the umbrella brand Cysticare / Utipro plus and is distributed by Vemedia, our partner for the product in the Netherlands as well.
We are pleased to announce the launch of UTIPRO® PLUS, our product for uncomplicated UTIs, in Finland. The product is commercialized over the Finnish territory under the umbrella brand UrinCUR / Utipro plus and it is distributed by RFSU, our partner for the product on the Swedish and Norwegian territory as well.
Future Microbiology. Published online: 3 March 2017
Aim:
Pathology International
Tight junctions are intercellular junctions adjacent to the apical ends of paracellular spaces. They have two classical functions, the barrier function and the fence function.
Noventure grants Axmer exclusive distribution right for its products Oleoabrax® EHO and EPA3G® in Sweden, Denmark, Norway, Finland, Estonia, Latvia and Lithuania.
Oleoabrax® EHO is a hydrogel whose patented formulation grants it the ability to promote and speed up the process of healing wounds of full and partial thickness.
Case Reports in Gastrointestinal Medicine, Volume 2012.
Utipro® Plus AF available for launch
We are pleased to announce the availability for launch of a new formulation of UTIPRO® PLUS, our product for uncomplicated UTIs.